Last reviewed · How we verify
NCT06348628
Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease
NA trial testing Motivational Interview in Non-Alcoholic Fatty Liver Disease in 231 participants. Completed in 24 June 2025.
22 April 2025
Quick facts
| Lead sponsor | Madunil Anuk Niriella |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 231 |
| Start date | 31 May 2022 |
| Primary completion | 22 April 2025 |
| Estimated completion | 24 June 2025 |
| Sites | 1 location across Sri Lanka |
Drugs / interventions tested
- Motivational Interview
- Placebo
Conditions studied
- Non-Alcoholic Fatty Liver Disease — all drugs for Non-Alcoholic Fatty Liver Disease →
Sponsor
Madunil Anuk Niriella
Who can join
Adults 18 to 60, any sex, with Non-Alcoholic Fatty Liver Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to assess if motivational counselling works to reduce the weight in participants with Non Alcoholic Fatty Liver Disease (NAFLD).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
- PubMed search for NCT06348628
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motivational Interview
Trials testing the same drug.
- NCT06656013 — Motivational Interview and Nomophobia · NA · completed
- NCT06195007 — Motivational Interviewing for Stroke · NA · terminated
- NCT06181890 — The Effect of Motivational Interviews · unknown
- NCT05646329 — The Effect of Motivational Interviewing on Problematic Internet Use and Loneliness · NA · unknown
- NCT06009887 — Motivational Interview in Primiparous Pregnants With Low Belief in Normal Birth · NA · completed
Other recruiting trials for Non-Alcoholic Fatty Liver Disease
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07294963 — Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease · NA · recruiting
- NCT07130318 — Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise · NA · recruiting
- NCT06355310 — Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease · Phase 2 · recruiting
- NCT06863376 — Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06348628 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Madunil Anuk Niriella
- Last refreshed: 30 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06348628.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing